Venetoclax for unfit AML: real-world outcomes of standard and azole-adjusted dosing in Brazilian public and private care
Authors:
- Pedro PerezPPPedro Perez
- Fábio Pires de Souza SantosFSFábio Pires de Souza Santos
- Renata Ribeiro QueirozRQRenata Ribeiro Queiroz
- Maria Luiza Barbosa Fernandes DouradoMDMaria Luiza Barbosa Fernandes Dourado
- Lisandra Bezerra GomesLGLisandra Bezerra Gomes
- André Dias AméricoAAAndré Dias Américo
- Vinicius Campos de MollaVMVinicius Campos de Molla
- Aline Raposo NishimotoANAline Raposo Nishimoto
- Celso Arrais-RodriguesCACelso Arrais-Rodrigues
- Nelson HamerschlakNHNelson Hamerschlak
- Alex Freire SandesASAlex Freire Sandes
- Fábio Rodrigues KerbauyFKFábio Rodrigues Kerbauy
Open Access
- 16 April 2026
- journal article
- Published by Elsevier in Blood Global Hematology
- Vol. 2 (3)
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Indications for haematopoietic cell transplantation and CAR-T for haematological diseases, solid tumours and immune disorders: 2025 EBMT practice recommendationsBone Marrow Transplantation, 2025
- Plasma concentrations of venetoclax and Pharmacogenetics correlated with drug efficacy in treatment naive leukemia patients: a retrospective studyThe Pharmacogenomics Journal, 2024
- Safety, Efficacy, and Predictive Factors of Venetoclax-Based Regimens in Elderly Acute Myeloid Leukemia Patients: A Meta-AnalysisClinical Lymphoma Myeloma and Leukemia, 2024
- Acute myeloid leukemia: challenges for diagnosis and treatment in Latin AmericaHematology, 2023
- The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic NeoplasmsLeukemia, 2022
- 10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trialThe Lancet Haematology, 2020
- Azacitidine and Venetoclax in Previously Untreated Acute Myeloid LeukemiaNew England Journal of Medicine, 2020
- Management of Venetoclax-Posaconazole Interaction in Acute Myeloid Leukemia Patients: Evaluation of Dose AdjustmentsClinical Therapeutics, 2017
- Access to cancer medications in low- and middle-income countriesNature Reviews Clinical Oncology, 2013
- The Brazilian health system: history, advances, and challengesThe Lancet, 2011